Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India

Context: To analyze the results of episcleral plaque brachytherapy using indigenous Bhabha Atomic Research Centre (BARC) Iodine-125 Ocu-Prosta seeds for the management of intraocular tumors from a single institute. AIM: To report our initial experience and learning curve on the use of ′BARC I-125 Oc...

Full description

Bibliographic Details
Main Authors: Parag K Shah, V Narendran, U Selvaraj, P Guhan, Sanjay K Saxena, Ashutosh Dash, Melvin Astrahan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=289;epage=295;aulast=Shah
id doaj-d807f1dac05e49c3985893a34b15d8ce
record_format Article
spelling doaj-d807f1dac05e49c3985893a34b15d8ce2020-11-24T22:02:39ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892012-01-0160428929510.4103/0301-4738.98708Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in IndiaParag K ShahV NarendranU SelvarajP GuhanSanjay K SaxenaAshutosh DashMelvin AstrahanContext: To analyze the results of episcleral plaque brachytherapy using indigenous Bhabha Atomic Research Centre (BARC) Iodine-125 Ocu-Prosta seeds for the management of intraocular tumors from a single institute. AIM: To report our initial experience and learning curve on the use of ′BARC I-125 Ocu-Prosta seeds′ for the management of intraocular tumors such as choroidal melanomas, retinoblastomas and vasoproliferative tumors (VPT). Materials and Methods: We retrospectively reviewed 13 eyes of 13 patients who underwent ophthalmic brachytherapy between May 2008 to March 2012. Nine cases had choroidal melanomas; three had retinoblastomas while one case had VPT. Results: For choroidal melanomas the average apical diameter before brachytherapy was 7.6 mm and average largest basal diameter was 12.1 mm, respectively, which reduced to 4.2 mm and 7.7 mm after the procedure at an average follow-up of 24 months (range 10-43 months). Retinoblastoma and VPT also showed good regression after brachytherapy. Conclusion: Plaque radiotherapy using 125 I seeds can be performed under peribulbar anesthesia and provides a viable option for the management of intraocular cancer with minimal invasiveness and surgical complications. Patients in our studies experienced excellent local tumor control. With the availability of indigenous ′BARC I-125 Ocu-Prosta seeds′ locally, cost effective ophthalmic brachytherapy can be performed in India.http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=289;epage=295;aulast=ShahApoptosisglaucomaintraocular pressureretinal ganglion cellsretinal ischemiatumor necrosis factor-alphaBranch retinal vein occlusionlaserLucentismacular edemaMicrobial etiologymucopurulent keratitissuppurative keratitisIntraoperative application of mitomycin Cmitomycin Cpostoperative complicationspreoperative subconjunctival injectionrecurrence raterecurrent pterygiumCataractinflammationmydriasisprevention and controlsurgeryCross-cylinder techniquephotoastigmatic refractive keratectomyrefractive surgery′BARC I-125 Ocu-Prosta seeds′choroidal melanomaplaque brachytherapyretinoblastomavasoproliferative tumorsAsian Indian
collection DOAJ
language English
format Article
sources DOAJ
author Parag K Shah
V Narendran
U Selvaraj
P Guhan
Sanjay K Saxena
Ashutosh Dash
Melvin Astrahan
spellingShingle Parag K Shah
V Narendran
U Selvaraj
P Guhan
Sanjay K Saxena
Ashutosh Dash
Melvin Astrahan
Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India
Indian Journal of Ophthalmology
Apoptosis
glaucoma
intraocular pressure
retinal ganglion cells
retinal ischemia
tumor necrosis factor-alpha
Branch retinal vein occlusion
laser
Lucentis
macular edema
Microbial etiology
mucopurulent keratitis
suppurative keratitis
Intraoperative application of mitomycin C
mitomycin C
postoperative complications
preoperative subconjunctival injection
recurrence rate
recurrent pterygium
Cataract
inflammation
mydriasis
prevention and control
surgery
Cross-cylinder technique
photoastigmatic refractive keratectomy
refractive surgery
′BARC I-125 Ocu-Prosta seeds′
choroidal melanoma
plaque brachytherapy
retinoblastoma
vasoproliferative tumors
Asian Indian
author_facet Parag K Shah
V Narendran
U Selvaraj
P Guhan
Sanjay K Saxena
Ashutosh Dash
Melvin Astrahan
author_sort Parag K Shah
title Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India
title_short Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India
title_full Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India
title_fullStr Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India
title_full_unstemmed Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India
title_sort episcleral plaque brachytherapy using ′barc i-125 ocu-prosta seeds′ in the treatment of intraocular tumors: a single-institution experience in india
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Ophthalmology
issn 0301-4738
1998-3689
publishDate 2012-01-01
description Context: To analyze the results of episcleral plaque brachytherapy using indigenous Bhabha Atomic Research Centre (BARC) Iodine-125 Ocu-Prosta seeds for the management of intraocular tumors from a single institute. AIM: To report our initial experience and learning curve on the use of ′BARC I-125 Ocu-Prosta seeds′ for the management of intraocular tumors such as choroidal melanomas, retinoblastomas and vasoproliferative tumors (VPT). Materials and Methods: We retrospectively reviewed 13 eyes of 13 patients who underwent ophthalmic brachytherapy between May 2008 to March 2012. Nine cases had choroidal melanomas; three had retinoblastomas while one case had VPT. Results: For choroidal melanomas the average apical diameter before brachytherapy was 7.6 mm and average largest basal diameter was 12.1 mm, respectively, which reduced to 4.2 mm and 7.7 mm after the procedure at an average follow-up of 24 months (range 10-43 months). Retinoblastoma and VPT also showed good regression after brachytherapy. Conclusion: Plaque radiotherapy using 125 I seeds can be performed under peribulbar anesthesia and provides a viable option for the management of intraocular cancer with minimal invasiveness and surgical complications. Patients in our studies experienced excellent local tumor control. With the availability of indigenous ′BARC I-125 Ocu-Prosta seeds′ locally, cost effective ophthalmic brachytherapy can be performed in India.
topic Apoptosis
glaucoma
intraocular pressure
retinal ganglion cells
retinal ischemia
tumor necrosis factor-alpha
Branch retinal vein occlusion
laser
Lucentis
macular edema
Microbial etiology
mucopurulent keratitis
suppurative keratitis
Intraoperative application of mitomycin C
mitomycin C
postoperative complications
preoperative subconjunctival injection
recurrence rate
recurrent pterygium
Cataract
inflammation
mydriasis
prevention and control
surgery
Cross-cylinder technique
photoastigmatic refractive keratectomy
refractive surgery
′BARC I-125 Ocu-Prosta seeds′
choroidal melanoma
plaque brachytherapy
retinoblastoma
vasoproliferative tumors
Asian Indian
url http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=289;epage=295;aulast=Shah
work_keys_str_mv AT paragkshah episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia
AT vnarendran episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia
AT uselvaraj episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia
AT pguhan episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia
AT sanjayksaxena episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia
AT ashutoshdash episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia
AT melvinastrahan episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia
_version_ 1725834671729672192